Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Fuji
UBS
McKinsey
Chinese Patent Office
Harvard Business School

Generated: September 19, 2019

DrugPatentWatch Database Preview

Litigation for naltrexone

  Try a free trial


See Plans and Pricing

« Back to Dashboard

US Court Litigation for naltrexone

Patent Case Name Docket Date Filed Date Terminated Cause Court Jury Demand Link To Docket
6,264,987 ➤ Sign Up ➤ Sign Up 2015-05-13 Court of Appeals for the Federal Circuit ➤ Sign Up
6,667,061 Alkermes Pharma Ireland Limited v. Luye Pharma Group Ltd. ➤ Sign Up 2019-07-17 35:271 Patent Infringement District Court, D. Delaware None ➤ Sign Up
>Patent >Case Name >Docket >Date Filed >Date Terminated >Cause >Court >Jury Demand >Link To Docket

Subscribe to access the full database, or try a Free Trial

Patent Trial and Appeal Board Cases for naltrexone

Patent Petitioner Status Filing Date Accorded Filing Date Patent Owner Trial Type Trial Number Decision Date Inventor Document Download
6,667,061 Luye Pharma Group Ltd. ➤ Sign Up 2016-05-31 2016-05-31 Alkermes Controlled Therapeutics, Inc. Inter partes review ➤ Sign Up 2016-11-30 J. Ramstack ➤ Sign Up
6,667,061 Luye Pharma Group Ltd. ➤ Sign Up 2016-05-31 2016-05-31 Ramstack et al Inter partes review ➤ Sign Up 2016-11-30 J. Ramstack ➤ Sign Up
7,919,499 Amneal Pharmaceuticals LLC ➤ Sign Up 2018-04-20 2018-05-09 Ehrich, Elliot Inter partes review ➤ Sign Up 2018-11-07 ➤ Sign Up
>Patent >Petitioner >Status >Filing Date >Accorded Filing Date >Patent Owner >Trial Type >Trial Number >Decision Date >Inventor >Document Download

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
QuintilesIMS
Fuji
Healthtrust
Daiichi Sankyo
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.